We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
-18.88%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$1.23B
AUM Growth
-$810M
Cap. Flow
-$536M
Cap. Flow %
-43.53%
Top 10 Hldgs %
62.76%
Holding
91
New
21
Increased
12
Reduced
15
Closed
12

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$29.8M
2
MU icon
Micron Technology
MU
+$19.2M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$12.8M
4
AAPL icon
Apple
AAPL
+$10.6M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$8.02M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$40.5M
2
TWTR
Twitter, Inc.
TWTR
+$14M
3
HMHC
Houghton Mifflin Harcourt Company
HMHC
+$10.5M
4
MPC icon
Marathon Petroleum
MPC
+$4.67M
5
PPLI
People Inc
PPLI
+$3.69M

Sector Composition

Rank Sector Weight
1 Financials 11.41%
2 Technology 6.81%
3 Materials 5.82%
4 Consumer Staples 3.88%
5 Energy 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUV icon
51
Southwest Airlines
LUV
$22.2B
$3.44M 0.28%
95,334
– –
BA icon
52
Boeing
BA
$167B
$3.27M 0.27%
23,932
– –
FSR
53
CALL
DELISTED
Fisker Inc.
FSR
$3M 0.24%
350,000
-100,000
-22% -$1.04M
BMRN icon
54
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.56M 0.21%
30,953
– –
SPCE icon
55
CALL
Virgin Galactic
SPCE
$325M
$2.41M 0.2%
+20,000
New +$2.9M
X
56
DELISTED
US Steel
X
$2.15M 0.17%
120,000
-30,000
-20% -$820K
TWTR
57
DELISTED
Twitter, Inc.
TWTR
$1.82M 0.15%
48,700
-326,522
-87% -$14M
ASA
58
ASA Gold and Precious Metals
ASA
$962M
$1.79M 0.15%
122,351
– –
LCID icon
59
PUT
Lucid Motors
LCID
$2.54B
$1.72M 0.14%
10,000
-50,000
-83% -$9.5M
FSR
60
PUT
DELISTED
Fisker Inc.
FSR
$1.71M 0.14%
200,000
+50,000
+33% +$518K
MPT
61
PUT
Medical Properties Trust
MPT
$2.86B
$1.53M 0.12%
+100,000
New +$1.8M
NTLA icon
62
Intellia Therapeutics
NTLA
$1.49B
$1.38M 0.11%
26,646
– –
SPCE icon
63
PUT
Virgin Galactic
SPCE
$325M
$1.2M 0.1%
10,000
-10,750
-52% -$1.56M
CRSP icon
64
CRISPR Therapeutics
CRSP
$4.6B
$1.15M 0.09%
18,876
– –
RARE icon
65
Ultragenyx Pharmaceutical
RARE
$2.65B
$948K 0.08%
15,885
– –
DAL icon
66
Delta Air Lines
DAL
$57B
$783K 0.06%
27,029
– –
WVE icon
67
Wave Life Sciences
WVE
$1.14B
$626K 0.05%
192,722
+150,000
+351% +$289K
GOEV
68
CALL
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$518K 0.04%
609
-870
-59% -$1.53M
TDOC icon
69
Teladoc Health
TDOC
$1.61B
$482K 0.04%
+14,500
New +$616K
EDIT icon
70
Editas Medicine
EDIT
$411M
$341K 0.03%
28,797
– –
SGMO
71
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$334K 0.03%
80,650
– –
SLN
72
Silence Therapeutics
SLN
$570M
$296K 0.02%
+25,000
New +$304K
AFMD
73
DELISTED
Affimed
AFMD
$277K 0.02%
+10,000
New +$342K
ADAP
74
DELISTED
Adaptimmune Therapeutics
ADAP
$197K 0.02%
115,602
– –
MPT
75
Medical Properties Trust
MPT
$2.86B
$153K 0.01%
+10,000
New +$180K
1 2
3
4

Similar funds

OHIF
Oriental Harbor Investment Fund Hong Kong $1.13B AUM 70.63% 1-Year Est. Return
HMCP
Hook Mill Capital Partners New York $1.13B AUM 31.32% 1-Year Est. Return
SAM
SP Asset Management Cupertino, California $1.13B AUM 12.57% 1-Year Est. Return
AT
American Trust Lexington, Kentucky $1.13B AUM 17.56% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
IP
Indivisible Partners Clearwater, Florida $1.13B AUM
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return

WS Management's Q2 2022 Portfolio in Review

As of Q2 2022, WS Management held 91 positions worth $1.23B, down 40% from $2.04B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

WS Management withdrew a net $536M in Q2 2022, closing 12 positions and reducing 15 holdings. Its most notable exit was Houghton Mifflin Harcourt Company, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 7.3% a quarter earlier, followed by Technology and Materials.

Against the trend, WS Management opened a new position in State Street SPDR S&P Biotech ETF worth $12.6M.

  • WS Management's largest Q2 2022 buy was State Street SPDR S&P Biotech ETF: 170,000 shares worth $12.6M.
  • WS Management added most to Berkshire Hathaway Class B in Q2 2022, an estimated $29.8M increase.
  • WS Management's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $40.5M.
  • WS Management fully exited Houghton Mifflin Harcourt Company in Q2 2022, selling an estimated $10.5M.
  • WS Management's ten largest holdings make up 63% of its $1.23B portfolio in Q2 2022.
  • WS Management opened 21 new positions and closed 12 in Q2 2022.
  • WS Management's portfolio value fell 40% quarter-over-quarter to $1.23B.

Based on WS Management's 13F filing for Q2 2022, filed 15 Aug 2022.